The diminished CXCR4 expression on HLA(−) and GPI(−) HSPCs contrasted with increased CXCR4 expression on HSPCs of patients with MDS previously reported [20, 21]. This evidence concerns the gene CXCR4 and myelodysplastic syndrome.